Clinical Trials in Philadelphia

Showing 14921-14940 of 20,904 trials

Diagnosis and Treatment of ACS in the ED: The Impact of Rapid Bedside cTnI Testing on Outcomes

NCT00222352

In a randomized, controlled clinical trial, point-of care testing at the bedside using the cardiac biomarker troponin I in ED patients with possible ACS will be compared to traditional testing of this assay for myocardial necrosis obtained in the central laboratory. Our hypothesis: point-of-care testing for troponin I will decrease the time for disposition of patients with possible ACS in the emergency setting and decrease the time required for administering appropriate therapies for these patients.

Angina, Unstable

University of Cincinnati2,000 participantsStarted Dec 2004

Stanford, California, United States • Royal Oak, Michigan, United States • Cincinnati, Ohio, United States +1 more locations

TERMINATEDPhase 1< 1 mile

A Study of DCC-2701 in Participants With Advanced Solid Tumors

NCT02228811

The main purpose of this study is to investigate the safety of the investigational drug DCC-2701 and whether it will work to help people who have advanced solid tumors or cancer that has spread to other parts of the body.

Locally Advanced TumorsMetastatic Solid TumorsCancers With MET Genomic Alterations+1 more

Deciphera Pharmaceuticals, LLC44 participantsStarted Jun 2014

Aurora, Colorado, United States • Boston, Massachusetts, United States • Philadelphia, Pennsylvania, United States +2 more locations

Diagnosis and Treatment of ACS in the ED: The Impact of Rapid Bedside cTnI Testing on Outcomes

A Study of DCC-2701 in Participants With Advanced Solid Tumors

Find Trials by Condition in Philadelphia

Study of Daptomycin in Subjects Undergoing Surgery for Osteomyelitis Associated With an Infected Prosthetic Caused by Staphylococci

A Study to Investigate Mepolizumab in the Treatment of Eosinophilic Granulomatosis With Polyangiitis

A Study of CDX-1127 (Varlilumab) in Patients With Select Solid Tumor Types or Hematologic Cancers

Bevacizumab, Cisplatin, Radiation Therapy, and Fluorouracil in Treating Patients With Stage IIB, Stage III, Stage IVA, or Stage IVB Nasopharyngeal Cancer

Using Feedback Reports to Improve Medication Adherence

Carboplatin and Paclitaxel Albumin-Stabilized Nanoparticle Formulation Followed by Radiation Therapy and Erlotinib in Treating Patients With Stage III Non-Small Cell Lung Cancer That Cannot Be Removed By Surgery

A 24-week Evaluation of GSK573719/Vilanterol (125/25mcg) and Components in COPD

NOLAN: Naproxen or Loratadine and Neulasta

Lesinurad and Febuxostat Combination Extension Study in Gout

Venlafaxine for Depression in Alzheimer's Disease (DIADs-3)

Evaluate the Efficacy and Safety of Arhalofenate for Preventing Flares and Reducing Serum Uric Acid in Gout Patients

An Active Treatment Study to Induce Clinical Response and/or Remission With GSK1605786A in Subjects With Crohn's Disease

A Study of Intravenous XMT-1001 in Patients With Advanced Solid Tumors

Lenalidomide and Idelalisib in Treating Patients With Recurrent Follicular Lymphoma

Validation of BD Onclarity™ HPV Assay With PreservCyt® -ASCUS Samples

AngioDefender Versus Brachial Artery Ultrasound Imaging

Efficacy and Safety of the Addition of Fluticanse Propionate/Salmeterol (250/50mcg) Twice-daily to 2 Doses of Umeclidinium Bromide (62.5 or 125mcg) Once-daily Over 12 Weeks

Safety and Tolerability Study of an Edible Colon Preparation